Platte River Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-47,280
Closed -$1.27M 217
2013
Q2
$1.27M Buy
+47,280
New +$1.27M 0.15% 142